BAFAX
Price
$45.56
Change
+$0.32 (+0.71%)
Updated
Sep 11 closing price
Net Assets
980.3M
VIGIX
Price
$271.86
Change
+$2.44 (+0.91%)
Updated
Sep 11 closing price
Net Assets
384.53B
Interact to see
Advertisement

BAFAX vs VIGIX

BAFAX vs VIGIX Comparison Chart in %
View a ticker or compare two or three
VS
BAFAX vs. VIGIX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFAX is a Buy and VIGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 385B vs. BAFAX (980M). VIGIX pays higher dividends than BAFAX: VIGIX (0.38) vs BAFAX (0.07). BAFAX was incepted earlier than VIGIX: BAFAX (20 years) vs VIGIX (28 years). BAFAX (0.92) is less costly to investors than VIGIX (0.03). BAFAX is a more actively managed with annual turnover of: 17.00 vs. VIGIX (12.00). BAFAX has a lower initial minimum investment than VIGIX: BAFAX (100) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 11.38 vs. BAFAX (2.30). VIGIX return over 5 years is better than : 71.94 vs. BAFAX (29.35).
BAFAXVIGIXBAFAX / VIGIX
Total Expense Ratio0.920.033,067%
Annual Report Gross Expense Ratio0.920.033,067%
Fund Existence20 years28 years-
Gain YTD7.0527.27597%
Front LoadN/AN/A-
Min. Initial Investment10050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets980M385B0%
Annual Yield % from dividends0.070.3818%
Returns for 1 year2.3011.3820%
Returns for 3 years39.0383.3147%
Returns for 5 years29.3571.9441%
Returns for 10 years184.29378.9349%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PASRX22.87N/A
N/A
Franklin Dynamic Asset Allocation Gr R
FNCFX2.54N/A
N/A
Franklin Income R6
RYBOX76.49N/A
N/A
Rydex Biotechnology A
NFEDX23.80N/A
N/A
Columbia Large Cap Growth Opp S
FGEHX27.14N/A
N/A
Fidelity Advisor® Global EquityInc C